Intestinal barrier functions in hematologic and oncologic diseases
Abstract The intestinal barrier is a complex structure that not only regulates the influx of luminal contents into the systemic circulation but is also involved in immune, microbial, and metabolic homeostasis. Evidence implicating disruption in intestinal barrier functions in the development of many...
Main Authors: | Elio Haroun, Prashanth Ashok Kumar, Ludovic Saba, Joseph Kassab, Krishna Ghimire, Dibyendu Dutta, Seah H. Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04091-w |
Similar Items
-
Endari treatment ameliorates sickle cell-related disruption in intestinal barrier functions and is associated with prolonged survival in sickle cell mice
by: Elio Haroun, et al.
Published: (2024-12-01) -
Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice
by: Maroun Bou Zerdan, et al.
Published: (2022-01-01) -
Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration
by: Meagan E. Miller, et al.
Published: (2023-08-01) -
Emerging Role of Biosimilars in Oncology-Hematology in Saudi Arabia: A Practical Perspective
by: Mansoor A. Khan, et al.
Published: (2020-02-01) -
Prospective infection surveillance and systematic screening for vancomycin-resistant enterococci in hematologic and oncologic patients – findings of a German tertiary care center
by: Patrick Chhatwal, et al.
Published: (2020-09-01)